Search for a doctor

Darrell S. Pardi, M.D.

  1. Gastroenterologist
Request an Appointment

Publications

  1. Bergman D, Roelstraete B, Sun J, Ebrahimi F, Butwicka A, Pardi DS, Ludvigsson JF. Psychiatric Disorders Among 5,800 Patients With Microscopic Colitis: A Nationwide Population-Based Matched Cohort Study. Am J Gastroenterol. 2024 Dec 1; 119 (12):2516-2525 Epub 2024 July 12
    View PubMed
  2. Gala K, Tome J, Krall M, Tian D, League JB, Vargas EJ, Pardi DS, Johnson AM, Coelho-Prabhu N. Quality of bowel preparation for colonoscopy in patients on glucagon-like peptide-1 receptor agonists. Gastrointest Endosc. 2024 Nov 16 [Epub ahead of print]
    View PubMed
  3. Allegretti JR, Kelly CR, Louie T, Fischer M, Hota S, Misra B, Van Hise NW, Yen E, Bullock JS, Silverman M, Davis I, McGill SK, Pardi DS, Orenstein R, Grinspan A, El-Nachef N, Feuerstadt P, Borody TJ, Khanna S, Budree S, Kassam Z. Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial. Gastroenterology. 2024 Oct 2 Epub 2024 Oct 02
    View PubMed
  4. Johnson K, Henry P, Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS, ECOSPOR III and ECOSPOR IV investigators. Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI. Infect Dis Ther. 2024 Oct; 13 (10):2105-2121 Epub 2024 June 28
    View PubMed
  5. Johnson K, Henry P, Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS, ECOSPOR III and ECOSPOR IV investigators. Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI. Infect Dis Ther. 2024 Oct; 13 (10):2209-2210
    View PubMed
  6. Peery AF, Khalili H, Munch A, Pardi DS. Update on the Epidemiology and Management of Microscopic Colitis. Clin Gastroenterol Hepatol. 2024 Sep 11 Epub 2024 Sept 11
    View PubMed
  7. Loufek B, Vidal D, McClintock DS, Lifson M, Williamson E, Overgaard S, McNaughton K, Lipford MC, Pardi DS. Embedding internal accountability into health care institutions for safe, effective, and ethical implementation of artificial intelligence into medical practice: a Mayo Clinic case study. Mayo Clinic Proceedings: Digital Health. 2024; 2(4):574-83.
  8. El Hage Chehade N, Ghoneim S, Shah S, Pardi DS, Farraye FA, Francis FF, Hashash JG. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2024 Sep 1; 58 (8):789-799 Epub 2024 Sept 01
    View PubMed
  9. Chehade NE, Ghoneim S, Shah S, Pardi DS, Farraye FA, Francis FF, Hashash JG. Efficacy and safety of vedolizumab and tumor necrosis factor inhibitors in the treatment of steroid-refractory microscopic colitis. Journal of Clinical Gastroenterology. 2024 Sep; 58 (8):789-99
  10. Tome J, Tariq R, Chelf CJ, Khanna S, Pardi DS. Effectiveness of Bile Acid Sequestrants in Microscopic Colitis and Utility of Bile Acid Testing: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2024 Sep 1; 119 (9):1792-1799 Epub 2024 June 12
    View PubMed
  11. Tome J, Tariq R, Hassett LC, Khanna S, Pardi DS. Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2024 Jul 3; 30 (7):1178-1188
    View PubMed
  12. Vincent ML, Aggarwal M, Chandrasekhara V, Pardi DS. Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents. ACG Case Rep J. 2024 Jul; 11 (7):e01417 Epub 2024 June 26
    View PubMed
  13. Tariq R, Loftus EV Jr, Pardi D, Khanna S. Durability and outcomes of fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with moderate to severe inflammatory bowel disease. Intest Res. 2024 Apr; 22 (2):208-212 Epub 2024 Jan 09
    View PubMed
  14. Zheng T, Roda G, Zabana Y, Escudero-Hernandez C, Liu X, Chen Y, Camargo Tavares L, Bonfiglio F, Mellander MR, Janczewska I, Vigren L, Sjoberg K, Ohlsson B, Almer S, Halfvarson J, Miehlke S, Madisch A, Lieb W, Kupcinskas J, Weersma RK, Bujanda L, Julia A, Marsal S, Esteve M, Guagnozzi D, Fernandez-Banares F, Ferrer C, Peter I, Ludvigsson JF, Pardi D, Verhaegh B, Jonkers D, Pierik M, Munch A, Franke A, Bresso F, Khalili H, Colombel JF, D'Amato M, MC-Europe GETECCU GWAS group. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes. J Crohns Colitis. 2024 Mar 1; 18 (3):349-359
    View PubMed
  15. Nielsen OH, Pardi DS. Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care. Drugs Aging. 2024 Feb; 41 (2):113-123 Epub 2024 Jan 17
    View PubMed
  16. Berenson CS, Lashner B, Korman LY, Hohmann E, Deshpande A, Louie TJ, Sims M, Pardi D, Kraft CS, Wang EEL, Cohen SH, Feuerstadt P, Oneto C, Misra B, Pullman J, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Lee CH. Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic. Clin Infect Dis. 2023 Nov 30; 77 (11):1504-1510
    View PubMed
  17. Koop AH, Travers PM, Khanna S, Pardi DS, Farraye FA, Hashash JG. Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2023 Nov; 38 (11):1910-1916 Epub 2023 June 19
    View PubMed
  18. Tome J, Sehgal K, Kamboj AK, Harmsen WS, Khanna S, Pardi DS. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clin Gastroenterol Hepatol. 2023 Nov; 21 (12):3125-3131.e2 Epub 2023 May 10
    View PubMed
  19. Sehgal K, Spiceland CM, Lennon RJ, Pardi DS, Khanna S. Clostridioides difficile Infection in Patients with Cirrhosis Treated for Hepatic Encephalopathy Journal of Gastrointestinal Infections. 2023; 13:26-29.
  20. Tariq R, Tosh PK, Pardi DS, Khanna S. Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection. Eur J Clin Microbiol Infect Dis. 2023 Aug; 42 (8):1037-1041 Epub 2023 June 23
    View PubMed
  21. Louie T, Golan Y, Khanna S, Bobilev D, Erpelding N, Fratazzi C, Carini M, Menon R, Ruisi M, Norman JM, Faith JJ, Olle B, Li M, Silber JL, Pardi DS. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. JAMA. 2023 Apr 25; 329 (16):1356-1366
    View PubMed
  22. Tariq R, Syed T, Yadav D, Prokop LJ, Singh S, Loftus EV Jr, Pardi DS, Khanna S. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2023 Mar 1; 57 (3):285-293 Epub 2023 Mar 01
    View PubMed
  23. Sims MD, Khanna S, Feuerstadt P, Louie TJ, Kelly CR, Huang ES, Hohmann EL, Wang EEL, Oneto C, Cohen SH, Berenson CS, Korman L, Lee C, Lashner B, Kraft CS, Ramesh M, Silverman M, Pardi DS, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, ECOSPOR IV Investigators. Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial. JAMA Netw Open. 2023 Feb 1; 6 (2):e2255758 Epub 2023 Feb 01
    View PubMed
  24. Tariq R, Pardi DS, Khanna S. Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis. Therap Adv Gastroenterol. 2023; 16:17562848231174293 Epub 2023 May 30
    View PubMed
  25. Saha S, Pardi R, Theiler RN, Pardi DS, Khanna S. Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study. Therap Adv Gastroenterol. 2023; 16:17562848231170479 Epub 2023 Apr 27
    View PubMed
  26. Sehgal K, Tome J, Kamboj AK, Dierkhising RA, Pardi DS, Khanna S. The natural history of histological changes in microscopic colitis. Therap Adv Gastroenterol. 2023; 16:17562848231168237 Epub 2023 Apr 27
    View PubMed
  27. Tome J, Raffals LE, Pardi DS. Management of Acute and Chronic Pouchitis. Dis Colon Rectum. 2022 Dec 1; 65 (S1):S69-S76 Epub 2022 July 25
    View PubMed
  28. Dunleavy K, Fogwe D, Forde G, Ho M, Stewart J, Youssef M, Perry W, Pardi D. A Rare Complication: Postoperative Pyoderma Gangrenosum in Segmental Colitis Associated With Diverticulosis. Am J Gastroenterol. 2022 Nov 1; 117 (11):1734 Epub 2022 Aug 23
    View PubMed
  29. Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Kotze PG, D'Hoore A, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Sep; 7(9):871-893. Epub 2022 Jul 05.
    View PubMed
  30. Tome J, Sehgal K, Kamboj AK, Comstock B, Harmsen WS, Khanna S, Pardi DS. Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile From a Population-Based Study. Am J Gastroenterol. 2022 Aug 1; 117 (8):1311-1315 Epub 2022 Apr 13
    View PubMed
  31. Nielsen OH, Fernandez-Banares F, Sato T, Pardi DS. Microscopic colitis: Etiopathology, diagnosis, and rational management. Elife. 2022 Aug 1; 11 Epub 2022 Aug 01
    View PubMed
  32. Kamboj AK, McGoldrick J, Voth E, Penrice D, Tome J, Gujral A, Miller K, Burke KE, Pardi DS, Khalili H. Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study. Dig Dis Sci. 2022 Jul; 67 (7):3108-3114 Epub 2021 July 20
    View PubMed
  33. Tome J, Sehgal K, Kamboj AK, Harmsen WS, Kammer PP, Loftus EV Jr, Tremaine WJ, Khanna S, Pardi DS. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019. Clin Gastroenterol Hepatol. 2022 May; 20 (5):1085-1094 Epub 2021 June 30
    View PubMed
  34. Sehgal K, Zandvakili I, Tariq R, Pardi DS, Khanna S. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert Rev Anti Infect Ther. 2022 Apr; 20(4):577-583. Epub 2021 Nov 01.
    View PubMed
  35. Kamboj AK, Zylberberg HM, Lane CM, Voth E, Tome J, Cuir ND, Lennon RJ, Khanna S, Lebwohl B, Pardi DS. Microscopic Colitis and Risk of Colon Adenomas: A Multicenter Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2022 Apr; 20 (4):e902-e904 Epub 2021 May 29
    View PubMed
  36. Fredrick TW, Ramos GP, Braga Neto MB, Kane S, Faubion WA, Loftus EV Jr, Pardi DS, Pasha SF, Farraye FA, Zhang L, Raffals LE. Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohns Colitis 360. 2022 Apr; 4 (2):otac008 Epub 2022 Mar 15
    View PubMed
  37. Koop AH, Salih A, Omer M, Kwon J, Ghoz HM, McCann M, Tome J, Palmer WC, Pardi DS, Stancampiano FF. Abnormal findings on abdominopelvic cross-sectional imaging in patients with microscopic colitis: a retrospective, multicenter study. Scand J Gastroenterol. 2022 Mar; 57 (3):298-304 Epub 2021 Dec 03
    View PubMed
  38. Saha S, Sehgal K, Singh S, Grover M, Pardi D, Khanna S. Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis. J Clin Gastroenterol. 2022 Feb 1; 56 (2):e84-e93
    View PubMed
  39. Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Jan; 7 (1):69-95 Epub 2021 Nov 10
    View PubMed
  40. Cho J, Vazquez M, Orenstein R, Loftus EV Jr, DiBaise J, Pardi DS, Khanna S. Fecal microbial transplantation is effective for postcolectomy recurrent Clostridioides difficile infection Journal of Gastrointestinal Infections. 2022; 12(1):36-40.
  41. Dunleavy KA, Pardi DS. Biologics: how far can they go in Crohn's disease? Gastroenterol Rep (Oxf). 2022; 10:goac049 Epub 2022 Sept 29
    View PubMed
  42. Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299
    View PubMed
  43. Khanna S, Pardi DS, Jones C, Shannon WD, Gonzalez C, Blount K. RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections. Clin Infect Dis. 2021 Oct 5; 73 (7):e1613-e1620
    View PubMed
  44. Saha S, Mara K, Pardi DS, Khanna S. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection. Clin Infect Dis. 2021 Oct 5; 73 (7):e1706-e1712
    View PubMed
  45. Shah BJ, Onken JE, Edgar L, Jou JH, Obstein KL, Pardi DS, Richter S, Reddy G, Rose S, Szyjkowski R, Fix OK. Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows. Am J Gastroenterol. 2021 Oct 1; 116 (10):2009-2013
    View PubMed
  46. Shah BJ, Onken JE, Edgar L, Jou JH, Obstein KL, Pardi DS, Richter S, Reddy G, Rose S, Szyjkowski R, Fix OK. Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows. Hepatology. 2021 Oct; 74 (4):2226-2232 Epub 2021 Sept 07
    View PubMed
  47. Shah BJ, Onken JE, Edgar L, Jou JH, Obstein KL, Pardi DS, Richter S, Reddy G, Rose S, Szyjkowski R, Fix OK. Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows. Gastrointest Endosc. 2021 Oct; 94 (4):665-670 Epub 2021 Sept 07
    View PubMed
  48. Shah BJ, Onken JE, Edgar L, Jou JH, Obstein KL, Pardi DS, Richter S, Reddy G, Rose S, Szyjkowski R, Fix OK. Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows. Gastroenterology. 2021 Oct; 161 (4):1318-1324 Epub 2021 Sept 07
    View PubMed
  49. Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 Oct; 6 (10):826-849 Epub 2021 Aug 18
    View PubMed
  50. Tariq R, Saha S, Solanky D, Pardi DS, Khanna S. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. J Clin Gastroenterol. 2021 Jul 1; 55 (6):542-547
    View PubMed
  51. Tariq R, Hayat M, Pardi D, Khanna S. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1383-1392. Epub 2021 Jan 26.
    View PubMed
  52. Ramos GP, Al-Bawardy B, Braga Neto MB, Bledsoe AC, Quinn KP, Heron V, Willrich MAV, Johnson A, Chedid VG, Coelho-Prabhu N, Kisiel JB, Papadakis KA, Pardi D, Kane S, Tremaine WJ, Raffals L, Bruining DH, Faubion WA, Harmsen WS, Loftus EV Jr. Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohns Colitis 360. 2021 Jul; 3 (3):otab019 Epub 2021 May 17
    View PubMed
  53. McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, O'Brien EJ, Desjardins CA, Bernardo P, Wortman JR, Lombardo MJ, Litcofsky KD, Winkler JA, McChalicher CWJ, Li SS, Tomlinson AD, Nandakumar M, Cook DN, Pomerantz RJ, Aunins JG, Trucksis M. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis. 2021 Jun 15; 72 (12):2132-2140
    View PubMed
  54. Burke KE, D'Amato M, Ng SC, Pardi DS, Ludvigsson JF, Khalili H. Microscopic colitis. Nat Rev Dis Primers. 2021 Jun 10; 7 (1):39 Epub 2021 June 10
    View PubMed
  55. Khanna S, Tande A, Rubin DT, Khoruts A, Kahn SA, Pardi DS. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations. Mayo Clin Proc. 2021 Jun; 96 (6):1418-1425
    View PubMed
  56. Zylberberg HM, Kamboj AK, De Cuir N, Lane CM, Khanna S, Pardi DS, Lebwohl B. Medication use and microscopic colitis: a multicentre retrospective cohort study. Aliment Pharmacol Ther. 2021 Jun; 53 (11):1209-1215 Epub 2021 Apr 14
    View PubMed
  57. Saha S, Mara K, Pardi DS, Khanna S. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 2021 May; 160 (6):1961-1969.e3 Epub 2021 Jan 11
    View PubMed
  58. Tome J, Kamboj AK, Pardi DS. Microscopic Colitis: A Concise Review for Clinicians. Mayo Clin Proc. 2021 May; 96 (5):1302-1308
    View PubMed
  59. Coelho-Prabhu N, Bruining DH, Faubion WA, Kane SV, Kisiel JB, Papadakis KA, Pardi DS, Raffals LE, Schroeder KW, Tremaine WJ, Fruth K, Harmsen WS, Loftus EV. A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy. Inflamm Bowel Dis. 2021 Apr 15; 27 (5):594-602
    View PubMed
  60. Kwapisz L, Raffals LE, Bruining DH, Pardi DS, Tremaine WJ, Kane SV, Papadakis KA, Coelho-Prabhu N, Kisiel JB, Heron V, Faubion WA, Loftus EV Jr. Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center. Clin Gastroenterol Hepatol. 2021 Mar; 19 (3):616-617 Epub 2020 Feb 14
    View PubMed
  61. Saha S, Yadav D, Pardi R, Patel R, Khanna S, Pardi D. Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection. Therap Adv Gastroenterol. 2021; 14:17562848211050443 Epub 2021 Oct 08
    View PubMed
  62. Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infect Drug Resist. 2021; 14:1645-1648 Epub 2021 Apr 28
    View PubMed
  63. Tariq R, Laguio-Vila M, Tahir MW, Orenstein R, Pardi DS, Khanna S. Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021; 14:1756284821994046 Epub 2021 Feb 23
    View PubMed
  64. Voth E, Solanky D, Loftus EV Jr, Pardi DS, Khanna S. Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection. Therap Adv Gastroenterol. 2021; 14:1756284821997792 Epub 2021 Mar 12
    View PubMed
  65. Tariq R, Disbrow MB, Dibaise JK, Orenstein R, Saha S, Solanky D, Loftus EV, Pardi DS, Khanna S. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Aug 20; 26 (9):1415-1420
    View PubMed
  66. Stahl E, Roda G, Dobbyn A, Hu J, Zhang Z, Westerlind H, Bonfiglio F, Raj T, Torres J, Chen A, Petras R, Pardi DS, Iuga AC, Levi GS, Cao W, Jain P, Rieder F, Gordon IO, Cho JH, D'Amato M, Harpaz N, Hao K, Colombel JF, Peter I. Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases. Gastroenterology. 2020 Aug; 159 (2):549-561.e8 Epub 2020 May 01
    View PubMed
  67. Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020 Aug; 95 (8):1632-1648 Epub 2020 June 10
    View PubMed
  68. Khanna S, Pardi D. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era. Am J Gastroenterol. 2020 Jul; 115 (7):971-974
    View PubMed
  69. Khanna S, Pardi D. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era. Am J Gastroenterol. 2020 May 20 [Epub ahead of print]
    View PubMed
  70. Cho JM, Pardi DS, Khanna S. Update on Treatment of Clostridioides difficile Infection. Mayo Clin Proc. 2020 Apr; 95 (4):758-769
    View PubMed
  71. Garg SK, Obaitan I, Sarvepalli S, Anugwom CM, Pardi DS, Khanna S. Clostridium difficile Infection in the Emergency Department. J Clin Gastroenterol. 2020 Apr; 54 (4):350-355
    View PubMed
  72. Saha S, Pardi R, Theiler RN, Pardi DS, Khanna S. Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study. Therap Adv Gastroenterol. 2020; 13:1756284820942621. Epub 2020 Jul 27.
    View PubMed
  73. Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2019 Nov 30; 11:CD001176
    View PubMed
  74. Park SH, Al-Bawardy B, Aniwan S, Kane SV, Coelho-Prabhu N, Papadakis KA, Kisiel JB, Bruining DH, Faubion WA, Raffals LE, Pardi DS, Tremaine WJ, Stephens MC, Tung J, Khanna S, Willrich, Loftus EV. Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease. Crohn's & Colitis 360. 2019; 1(3):otz047.
  75. Cho J, Pardi D, Khanna S. Update on Treatment of Clostridiodes difficile infection Mayo Clinic Proceedings. 2019; in press.
  76. Aniwan S, Bruining DH, Park SH, Pardi DS, Tremaine WJ, Loftus EV. The combination of an ulcerative colitis symptom score and an endoscopic score correlates well with patient reported outcomes in patients with ulcerative colitis. Clin Gastroenterol Hepatology. 2019; submitted.
  77. Shen, Kochhar, Navaneetthan, Chen, Liu, Bruining, Lukas, Pardi. Bridging Medical and Surgical Treatment of Inflammatory Bowel Disease: The Role of Interventional IBD Am J Gastroenterol. 2019; in press.
  78. Saha S,, Pardi R, Theiler RN, Pardi DS, Khanna S . Increasing incidence of peripartum Clostridioides difficiel infection na. 2019.
  79. Kwapisz, L, Raffals, L, Bruining, D, Pardi, D. Combination biologic therapy in inflammatory bowel disease Inflammaotry Bowel Disease. 2019.
  80. Aniwan S, Bruining DH, Park SH, Al-Bawardy B, Kane SV, Coelho Prabhu N, Kisiel JB, Raffals LE, Papadakis KA, Pardi DS, Tremaine WJ, Loftus EV Jr. The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. J Clin Med. 2019 Aug 5; 8 (8) Epub 2019 Aug 05
    View PubMed
  81. Saha S, Tariq R, Tosh PK, Pardi DS, Khanna S. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review. Clin Microbiol Infect. 2019 Aug; 25 (8):958-963 Epub 2019 Apr 12
    View PubMed
  82. Saha S, Kapoor S, Tariq R, Schuetz AN, Tosh PK, Pardi DS, Khanna S. Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis. Anaerobe. 2019 Aug; 58:35-46. Epub 2019 Jul 19.
    View PubMed
  83. Cho JM, Pestana L, Pardi R, Pardi DS, Khanna S. Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings. Intest Res. 2019 Jul; 17 (3):434-437 Epub 2019 May 31
    View PubMed
  84. Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2019 May 28; 5:CD001176
    View PubMed
  85. Tariq R, Pardi DS, Bartlett MG, Khanna S. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. 2019 Apr 08; 68(8):1351-1358.
    View PubMed
  86. Solanky D, Pardi DS, Loftus EV, Khanna S. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflamm Bowel Dis. 2019 Feb 21; 25 (3):610-619
    View PubMed
  87. Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, Bruining D, Pardi DS, Lukas M, Bortlik M, Wu K, Sood A, Schwartz DA, Sandborn WJ, Global Interventional Inflammatory Bowel Disease Group. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019 Feb; 89 (2):215-237 Epub 2018 Oct 24
    View PubMed
  88. Saha, Pardi, Theiler, Pardi, Khanna,. Increasing incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study Ann Internal Medicine. 2019.
  89. Battaglioli EJ, Hale VL, Chen J, Jeraldo P, Ruiz-Mojica C, Schmidt BA, Rekdal VM, Till LM, Huq L, Smits SA, Moor WJ, Jones-Hall Y, Smyrk T, Khanna S, Pardi DS, Grover M, Patel R, Chia N, Nelson H, Sonnenburg JL, Farrugia G, Kashyap PC. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci Transl Med. 2018 Oct 24; 10 (464)
    View PubMed
  90. Aniwan S, Pardi DS, Tremaine WJ, Loftus EV. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018 Oct; 16 (10):1607-1615.e1 Epub 2018 Apr 24
    View PubMed
  91. Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, Nelson S, Stitt L, Bloom S, Pardi DS, Gionchetti P, Lindsay J, Travis S, Hart A, Silverberg MS, Feagan BG, D'Haens GR, Jairath V. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointest Endosc 2018 Aug; 88 (2):360-369.e2 Epub 2018 Apr 13
    View PubMed
  92. Hansel SL, McCurdy JD, Barlow JM, Fidler J, Fletcher JG, Becker B, Prabhu NC, Faubion WA, Hanson KA, Kane SV, Kisiel JB, Loftus EV Jr, Papadakis KA, Pardi DS, Raffals LE, Schoenoff S, Tremaine WJ, Bruining DH. Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. Inflamm Bowel Dis. 2018 Jun 8; 24 (7):1582-1588
    View PubMed
  93. Cho J, Seville MT, Khanna S, Pardi DS, Sampathkumar P, Kashyap PC. Screening for Clostridium difficile colonization on admission to a hematopoietic stem cell transplant unit may reduce hospital-acquired C difficile infection. Am J Infect Control. 2018 Apr; 46 (4):459-461 Epub 2017 Nov 21
    View PubMed
  94. Hanada Y, Khanna S, Loftus EV Jr, Raffals LE, Pardi DS. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 Apr; 16 (4):528-533 Epub 2017 Oct 14
    View PubMed
  95. Sacco KA, Pongdee T, Binnicker MJ, Espy M, Pardi D, Khanna S, Joshi AY. Presence of immune deficiency increases the risk of hospitalization in patients with norovirus infection. Diagn Microbiol Infect Dis. 2018 Apr; 90 (4):300-306 Epub 2017 Dec 05
    View PubMed
  96. Cotter TG, Binder M, Loftus EV Jr, Abboud R, McNally MA, Smyrk TC, Tremaine WJ, Sandborn WJ, Pardi DS. Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study. Gut. 2018 Mar; 67 (3):441-446 Epub 2016 Dec 13
    View PubMed
  97. Spiceland CM, Khanna S, Pardi DS. Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection. J Clin Gastroenterol. 2018 Feb; 52 (2):151-154
    View PubMed
  98. Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection. J Clin Gastroenterol. 2018 Feb; 52(2):146-150.
    View PubMed
  99. Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Clin Infect Dis. 2018 Feb 01; 66(4):514-522.
    View PubMed
  100. Tariq R, Mukhija D, Gupta A, Singh S, Pardi DS, Khanna S. Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis. Infect Drug Resist. 2018; 11:405-416 Epub 2018 Mar 13
    View PubMed
  101. Pardi, Friedman. Sclerosing Mesenteritis Up to Date. 2018.
  102. Saffouri G, Gupta A, Loftus EV Jr, Baddour LM, Pardi DS, Khanna S. The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease. Scand J Gastroenterol. 2017 Nov; 52 (11):1240-1247 Epub 2017 Aug 06
    View PubMed
  103. Hefazi M, Patnaik MM, Hogan WJ, Litzow MR, Pardi DS, Khanna S. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series. Mayo Clin Proc. 2017 Nov; 92 (11):1617-1624 Epub 2017 Nov 01
    View PubMed
  104. Cotter TG, Kamboj AK, Hicks SB, Tremaine WJ, Loftus EV Jr, Pardi DS. Case report: Pentoxifylline treatment in microscopic colitis. Medicine (Baltimore). 2017 Nov; 96 (46):e8355
    View PubMed
  105. Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017 Oct 30; 65(10):1745-1747.
    View PubMed
  106. Tariq, Mukhija, Gupta, Singh, Pardi, Khanna. Statins may decrease the risk of Clostridium difficile infection: A systematic review and meta-analysis J Clinc Gastro 2017. 2017.
  107. Shivashankar R, Pardi DS. Use of Anti-Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease. Gastroenterol Clin North Am. 2017 Sep; 46 (3):589-601
    View PubMed
  108. Tariq R, Weatherly RM, Kammer PP, Pardi DS, Khanna S. Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice. Mayo Clin Proc Innov Qual Outcomes. 2017 Jul; 1(1):49-56. Epub 2017 May 19.
    View PubMed
  109. Cotter TG, Kamboj AK, Hicks SB, Tremaine WJ, Loftus EV, Pardi DS. Immune modulator therapy for microscopic colitis in a case series of 73 patients. Aliment Pharmacol Ther. 2017 Jul; 46 (2):169-174 Epub 2017 May 10
    View PubMed
  110. Cotter TG, Gathaiya N, Catania J, Loftus EV Jr, Tremaine WJ, Baddour LM, Harmsen WS, Zinsmeister AR, Sandborn WJ, Limper AH, Pardi DS. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression. Clin Gastroenterol Hepatol. 2017 Jun; 15 (6):850-856 Epub 2016 Dec 21
    View PubMed
  111. Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017 Jun 01; 177(6):784-791.
    View PubMed
  112. Khanna S, Vazquez-Baeza Y, Gonzalez A, Weiss S, Schmidt B, Muniz-Pedrogo DA, Rainey JF 3rd, Kammer P, Nelson H, Sadowsky M, Khoruts A, Farrugia SL, Knight R, Pardi DS, Kashyap PC. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome. 2017 May 15; 5 (1):55
    View PubMed
  113. Lightner AL, Pemberton JH, Dozois EJ, Larson DW, Cima RR, Mathis KL, Pardi DS, Andrew RE, Koltun WA, Sagar P, Hahnloser D. The surgical management of inflammatory bowel disease. Curr Probl Surg. 2017 Apr; 54 (4):172-250 Epub 2017 Feb 21
    View PubMed
  114. Gupta A, Tariq R, Frank RD, Jean GW, Beg MS, Pardi DS, Johnson DH, Khanna S. Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis. J Natl Compr Canc Netw. 2017 Apr; 15(4):466-472.
    View PubMed
  115. Lightner ,, Pemberton ,, Dozois ,, Larson ,, Cima ,, Mathis ,, Pardi ,. In Brief Current Problems in Surgery. 2017; 54(4):163-6.
  116. Lightner Amy, Pemberton John, Dozois Eric, Larson David, Cima Robert, Mathis Kellie, Pardi Darrell. In Brief Current Problems in Surgery. 2017; 54(4):163-6.
  117. Cotter TG, Binder M, Harper EP, Smyrk TC, Pardi DS. Optimization of a Scoring System to Predict Microscopic Colitis in a Cohort of Patients With Chronic Diarrhea. J Clin Gastroenterol. 2017 Mar; 51 (3):228-234
    View PubMed
  118. Schiller LR, Pardi DS, Sellin JH. Chronic Diarrhea: Diagnosis and Management. Clin Gastroenterol Hepatol. 2017 Feb; 15 (2):182-193.e3 Epub 2016 Aug 02
    View PubMed
  119. Cotter TG, Pardi DS. Current Approach to the Evaluation and Management of Microscopic Colitis. Curr Gastroenterol Rep. 2017 Feb; 19 (2):8
    View PubMed
  120. Malikowski T, Khanna S, Pardi DS. Fecal microbiota transplantation for gastrointestinal disorders. Curr Opin Gastroenterol. 2017 Jan; 33 (1):8-13
    View PubMed
  121. Lightner AL, Pemberton JH, Dozois EJ, Larson DW, Cima RR, Mathis KL, Pardi DS, Andrew RE, Koltun WA, Sagar P, Hahnloser D. In brief Current Problems in Surgery. 2017; 54: (4)163-6.
  122. Pardi DS. Diagnosis and Management of Microscopic Colitis. Am J Gastroenterol. 2017 Jan; 112 (1):78-85 Epub 2016 Nov 29
    View PubMed
  123. Cotter, Kamboj, Hicks, Tremaine, Loftus, Pardi. Pentoxifylline Treatment in Microscopic Colitis: A Case Series Medicine. 2017; 96:8355.
  124. Gupta A, Pardi DS, Baddour LM, Khanna S. Outcomes in children with Clostridium difficile infection: results from a nationwide survey. Gastroenterol Rep (Oxf). 2016 Nov; 4 (4):293-298 Epub 2016 Apr 14
    View PubMed
  125. Khanna S, Pardi DS. Clinical implications of antibiotic impact on gastrointestinal microbiota and clostridium difficile infection Expert Review Of Gastroenterology & Hepatology. 2016 Oct; 10: (10)1145-52.
  126. Khanna S, Pardi DS. Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection. Expert Rev Gastroenterol Hepatol. 2016 Oct; 10 (10):1145-1152 Epub 2016 Mar 16
    View PubMed
  127. Khanna S, Montassier E, Schmidt B, Patel R, Knights D, Pardi DS, Kashyap P. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection. Aliment Pharmacol Ther. 2016 Oct; 44 (7):715-727 Epub 2016 Aug 02
    View PubMed
  128. Wadhwa A, Al Nahhas MF, Dierkhising RA, Patel R, Kashyap P, Pardi DS, Khanna S, Grover M. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther. 2016 Sep; 44 (6):576-82 Epub 2016 July 22
    View PubMed
  129. Taleban S, Stewart KO, Li DK, Singh P, Pardi DS, Sturgeon HC, Yajnik V, Xavier RJ, Ananthakrishnan AN, Khalili H. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes. Dig Dis Sci. 2016 Sep; 61 (9):2627-35 Epub 2016 May 03
    View PubMed
  130. Khanna S, Gupta A, Baddour LM, Pardi DS. Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection. Intern Emerg Med. 2016 Aug; 11 (5):657-65 Epub 2015 Dec 22
    View PubMed
  131. Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo MJ, Vulic M, Ohsumi T, Winkler J, Pindar C, McGovern BH, Pomerantz RJ, Aunins JG, Cook DN, Hohmann EL. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. J Infect Dis. 2016 Jul 15; 214 (2):173-81 Epub 2016 Feb 08
    View PubMed
  132. Martinez Ugarte ML, Lightner AL, Colibaseanu D, Khanna S, Pardi DS, Dozois EJ, Mathis KL. Clostridium difficile infection after restorative proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis. Colorectal Dis. 2016 May; 18 (5):O154-7
    View PubMed
  133. Tariq R, Smyrk T, Pardi DS, Tremaine WJ, Khanna S. New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation. Am J Gastroenterol 2016 May; 111 (5):751-2
    View PubMed
  134. Deepak P, Hanson GJ, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Wong Kee Song LM, Harmsen WS, Loftus EV Jr, Bruining DH. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016 May; 83: (5)1005-12.
    View PubMed
  135. Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PUNCH CD Investigators. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study. Clin Infect Dis. 2016 Mar 1; 62 (5):596-602 Epub 2015 Nov 12
    View PubMed
  136. Dosanjh G, Pardi DS. Chronic unexplained diarrhea: a logical and cost-effective approach to assessment. Curr Opin Gastroenterol. 2016 Jan; 32: (1)55-60.
    View PubMed
  137. Pardi DS, Tremaine WJ, Carrasco -Labra A. AGA Institute Technical Review on the Medical Management of Microscopic colitis Gastroenterology. 2016; 150(1):247-74.e11.
  138. Weber NK, Fletcher JG, Fidler JL, Barlow JM, Pruthi S, Loftus EV Jr, Pardi DS, Smyrk TC, Becker BD, Pasha SF, Bruining DH. Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's disease. Abdom Imaging. 2015 Jun; 40 (5):1060-7
    View PubMed
  139. Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015 May 5; 313 (17):1719-27
    View PubMed
  140. Pardi DS. Microscopic colitis (invited review). Am J Gastroenterol. 2015.
  141. *Dosanjh G, Pardi DS. Chronic unexplained diarrhea. A logical and cost-effective approach to assessment ( Curr Opin Gastroenterol. 2015; invited review).
  142. Taleban S, Stewart KO, Li DK, Singh P, Pardi DS, et al. Clinical Actity and quality of Life Indices do not Vary According to Disease Phenotype in Inflammatory Bowel Disease Inflammatory Bowel Disease. 2015.
  143. Singh S, Stroud AM, Holubar SD, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis Cochrane Database Of Systematic Reviews. 2015; (11)(11)CD001176.
    View PubMed
  144. Singh S, Kullo IJ, Pardi DS, Loftus EV Jr. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015 Jan; 12 (1):26-35 Epub 2014 Dec 02
    View PubMed
  145. Singh S, Garg SK, Pardi DS, Wang Z, Murad MH, Loftus EV Jr. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis. Gastroenterology. 2015 Jan; 148 (1):64-76.e2; quiz e14 Epub 2014 Sept 26
    View PubMed
  146. Singh S, Garg SK, Pardi DS, Wang Z, Murad MH, Loftus EV Jr. Comparative efficacy of biologic therapy in biologic-naive patients with Crohn disease: a systematic review and network meta-analysis. Mayo Clin Proc. 2014 Dec; 89 (12):1621-35 Epub 2014 Oct 29
    View PubMed
  147. Rose, S, Fix, OK, Pardi DS. Entrustable Professional Activities for Gastroenterology Gastroenterology. 2014; 147:233-42.
  148. Gupta A, Patel R, Baddour LM, Pardi DS, Khanna S. Extraintestinal Clostridium difficile infections: a single-center experience. Mayo Clin Proc. 2014 Nov; 89 (11):1525-36 Epub 2014 Sept 20
    View PubMed
  149. Singh S, Pardi DS. Update on anti-tumor necrosis factor agents in Crohn disease. Gastroenterol Clin North Am. 2014 Sep; 43 (3):457-78 Epub 2014 June 24
    View PubMed
  150. Shivashankar R, Khanna S, Kammer PP, Scott Harmsen W, Zinsmeister AR, Baddour LM, Pardi DS. Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther. 2014 Sep; 40 (5):518-22 Epub 2014 July 10
    View PubMed
  151. Saffouri G, Khanna S, Estes L, Pardi D. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection. Am J Gastroenterol 2014 Jun; 109 (6):924-5
    View PubMed
  152. Gentile NM, Khanna S, Loftus EV Jr, Smyrk TC, Tremaine WJ, Harmsen WS, Zinsmeister AR, Kammer PP, Pardi DS. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol. 2014 May; 12 (5):838-42 Epub 2013 Oct 09
    View PubMed
  153. Weber NK, Fidler JL, Keaveny TM, Clarke BL, Khosla S, Fletcher JG, Lee DC, Pardi DS, Loftus EV Jr, Kane SV, Barlow JM, Murthy NS, Becker BD, Bruining DH. Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography. Am J Gastroenterol. 2014 Mar; 109 (3):401-8 Epub 2014 Jan 21
    View PubMed
  154. Singh S, Singh H, Loftus EV Jr, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Mar; 12 (3):382-93.e1: quiz e22 Epub 2013 Aug 24
    View PubMed
  155. Khanna S, Pardi DS. Clostridium difficile infection: management strategies for a difficult disease. Therap Adv Gastroenterol. 2014 Mar; 7 (2):72-86
    View PubMed
  156. Singh S, Nagpal SJ, Murad MH, Yadav S, Kane SV, Pardi DS, Talwalkar JA, Loftus EV Jr. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Feb; 12 (2):210-8 Epub 2013 May 02
    View PubMed
  157. Pardi DS. Microscopic colitis. Clin Geriatr Med. 2014 Feb; 30 (1):55-65
    View PubMed
  158. Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA, Krejs GJ, Farthing MJ, Sellin JH. Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol. 2014 Jan; 29(1):6-25.
    View PubMed
  159. Kane SV, Neis B, Becker BD, Bruining D, Faubion WA, Kisiel J, Loftus EV Jr, Pardi D, Raffals L, Schroeder K, Tremaine WJ. Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease. Aliment Pharmacol Ther 2013 Dec; 38 (11-12):1412
    View PubMed
  160. Weber NK, Bruining DH, Loftus EV Jr, Tremaine WJ, Augustin JJ, Becker BD, Kammer PP, Harmsen WS, Zinsmeister AR, Pardi DS. Comparative outcomes of younger and older hospitalized patients with inflammatory bowel disease treated with corticosteroids. Inflamm Bowel Dis. 2013 Nov; 19 (12):2644-51
    View PubMed
  161. Narla NP, Smyrk TC, Pardi DS, Tung J. Clinical features and treatment responses in pediatric lymphocytic and collagenous colitis. J Pediatr Gastroenterol Nutr. 2013 Nov; 57 (5):557-61
    View PubMed
  162. Shivashankar R, Khanna S, Kammer PP, Harmsen WS, Zinsmeister AR, Baddour LM, Pardi DS. Clinical factors associated with development of severe-complicated Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013 Nov; 11 (11):1466-71 Epub 2013 May 20
    View PubMed
  163. Eaton JE, Smyrk TC, Imam M, Pardi DS, Loftus EV Jr, Owens VL, Talwalkar JA. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Aliment Pharmacol Ther. 2013 Oct; 38 (8):977-87 Epub 2013 Aug 29
    View PubMed
  164. McCurdy JD, Loftus EV Jr, Tremaine WJ, Smyrk TC, Bruining DH, Pardi DS, Raffals LE, Kisiel JB, Coelho-Prabhu N, Kane SV, Faubion WA, Papadakis KA. Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes. Inflamm Bowel Dis. 2013 Oct; 19 (11):2394-9
    View PubMed
  165. Rajan E, Iyer PG, Oxentenko AS, Pardi DS, Alexander JA, Baron TH, Bruining DH, Hansel SL, Larson MV, Murray JA, Debritto J, Dierkhising RA, Gostout CJ. Training in small-bowel capsule endoscopy: assessing and defining competency. Gastrointest Endosc. 2013 Oct; 78(4):617-22. Epub 2013 Jul 25.
    View PubMed
  166. Katz S, Surawicz C, Pardi DS. Management of the elderly patients with inflammatory bowel disease: practical considerations. Inflamm Bowel Dis. 2013 Sep; 19(10):2257-72.
    View PubMed
  167. Khanna S, Keddis MT, Noheria A, Baddour LM, Pardi DS. Acute kidney injury is an independent marker of severity in Clostridium difficile infection: a nationwide survey. J Clin Gastroenterol. 2013 Jul; 47(6):481-4.
    View PubMed
  168. Singh S, Khanna S, Pardi DS, Loftus EV Jr, Talwalkar JA. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2013 Jul; 19 (8):1631-8
    View PubMed
  169. Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR, Harmsen WS, Pardi DS. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis. 2013 May; 56 (10):1401-6 Epub 2013 Feb 13
    View PubMed
  170. Gerich ME, Pardi DS, Bruining DH, Kammer PP, Becker BD, Tremaine WT. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease. Inflamm Bowel Dis. 2013 May; 19: (6)1107-11.
    View PubMed
  171. Singh S, Sharma PK, Loftus EV Jr, Pardi DS. Meta-analysis: serological markers and the risk of acute and chronic pouchitis. Aliment Pharmacol Ther. 2013 May; 37 (9):867-75 Epub 2013 Mar 11
    View PubMed
  172. Khanna S, Baddour LM, Dibaise JK, Pardi DS. Appendectomy is not associated with adverse outcomes in clostridium difficile infection: a population-based study. Am J Gastroenterol 2013 Apr; 108 (4):626-7
    View PubMed
  173. Abboud R, Pardi DS, Tremaine WJ, Kammer PP, Sandborn WJ, Loftus EV Jr. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study. Inflamm Bowel Dis. 2013 Mar; 19 (3):550-3
    View PubMed
  174. Gentile NM, Abdalla AA, Khanna S, Smyrk TC, Tremaine WJ, Faubion WA, Kammer PP, Sandborn WJ, Loftus EV Jr, Pardi DS. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol. 2013 Feb; 108 (2):256-9 Epub 2013 Jan 08
    View PubMed
  175. Samuel S, Bruining DH, Loftus EV Jr, Thia KT, Schroeder KW, Tremaine WJ, Faubion WA, Kane SV, Pardi DS, de Groen PC, Harmsen WS, Zinsmeister AR, Sandborn WJ. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol. 2013 Jan; 11 (1):49-54.e1 Epub 2012 Aug 16
    View PubMed
  176. Kane SV, Horst S, Sandborn WJ, Becker B, Neis B, Moscandrew M, Hanson KA, Tremaine WJ, Bruining DH, Faubion WA, Pardi DS, Harmsen WS, Zinsmeister AR, Loftus EV. Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience. Inflamm Bowel Dis. 2012 Dec; 18 (12):2203-8 Epub 2012 Mar 14
    View PubMed
  177. Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012 Nov; 87 (11):1106-17
    View PubMed
  178. Keddis MT, Khanna S, Noheria A, Baddour LM, Pardi DS, Qian Q. Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc. 2012 Nov; 87 (11):1046-53
    View PubMed
  179. Khanna S, Pardi DS, Rosenblatt JE, Patel R, Kammer PP, Baddour LM. An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol. 2012 Nov-Dec; 46 (10):846-9
    View PubMed
  180. Gentile NM, Murray JA, Pardi DS. Autoimmune enteropathy: a review and update of clinical management. Curr Gastroenterol Rep. 2012 Oct; 14 (5):380-5
    View PubMed
  181. Yen EF, Pardi DS. Non-IBD colitides (eosinophilic, microscopic). Best Pract Res Clin Gastroenterol. 2012 Oct; 26(5):611-22.
    View PubMed
  182. Khanna S, Aronson SL, Kammer PP, Baddour LM, Pardi DS. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study. Mayo Clin Proc. 2012 Jul; 87 (7):636-42
    View PubMed
  183. Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther. 2012 Mar; 35 (5):613-8 Epub 2012 Jan 10
    View PubMed
  184. Bruining DH, Siddiki HA, Fletcher JG, Sandborn WJ, Fidler JL, Huprich JE, Mandrekar JN, Harmsen WS, Evans PE, Faubion WA, Hanson KA, Ingle SB, Pardi DS, Schroeder KW, Tremaine WJ, Loftus EV Jr. Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis. 2012 Feb; 18 (2):219-25 Epub 2011 Feb 17
    View PubMed
  185. Pardi DS. Miscellaneous colitides. Curr Opin Gastroenterol. 2012 Jan; 28(1):76-81.
    View PubMed
  186. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012 Jan; 107 (1):89-95 Epub 2011 Nov 22
    View PubMed
  187. Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011 Nov; 106(11):1889-97. Epub 2011 Aug 23.
    View PubMed
  188. Thackeray EW, Pardi DS, Norby SM, Oxentenko AS. Mentorship programs for gastroenterology program directors: is there an unmet need? J Clin Gastroenterol. 2011 Nov-Dec; 45(10):e97-100.
    View PubMed
  189. Yen EF, Pardi DS. Review of the microscopic colitides. Curr Gastroenterol Rep. 2011 Oct; 13(5):458-64.
    View PubMed
  190. Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011 Sep; 106 (9):1638-45 Epub 2011 May 10
    View PubMed
  191. Yen EF, Pardi DS. Review article: Microscopic colitis--lymphocytic, collagenous and 'mast cell' colitis. Aliment Pharmacol Ther. 2011 Jul; 34(1):21-32. Epub 2011 May 04.
    View PubMed
  192. Thia KT, Loftus EV Jr, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis. 2011 Jun; 17 (6):1257-64 Epub 2010 Sept 27
    View PubMed
  193. Harewood GC, Pardi DS, Hansel SL, Corr AE, Aslanian H, Maple J. What do gastroenterology trainees want: recognition, remuneration or recreation? Ir J Med Sci. 2011 Jun; 180(2):439-44. Epub 2010 Jul 27
    View PubMed
  194. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011 Apr; 140 (4):1155-65 Epub 2011 Feb 22
    View PubMed
  195. Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, Schoenfeld PS. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011 Feb; 56(2):569-77. Epub 2010 Oct 27.
    View PubMed
  196. Pardi DS. Miscellaneous colitides (invited review). Curr Opin Gastroenterol. 2011.
  197. Pardi DS. New ACGME Program Requirements: What You Need to Know (invited review). AGA Perspectives Dec /Jan 2012. 2011/Jan.
  198. Swoger JM, Loftus EV Jr, Tremaine WJ, Faubion WA, Pardi DS, Kane SV, Hanson KA, Harmsen WS, Zinsmeister AR, Sandborn WJ. Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients. Inflamm Bowel Dis. 2010 Nov; 16 (11):1912-21
    View PubMed
  199. Decross AJ, Pardi DS, Proctor DD. Report of the AGA Institute Education and Training Committee Task Force on physician reentry. Gastroenterology. 2010 Sep; 139(3):e17-26.
    View PubMed
  200. Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2010 Aug; 4 (4):409-16
    View PubMed
  201. Hussain SW, Pardi DS. Inflammatory bowel disease in the elderly. Drugs Aging. 2010 Aug 1; 27 (8):617-24
    View PubMed
  202. Holubar SD, Cima RR, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD001176 Epub 2010 June 16
    View PubMed
  203. Guimaraes LS, Fidler JL, Fletcher JG, Bruining DH, Huprich JE, Siddiki H, Sandborn WJ, Loftus EV Jr, Pardi DS, McCollough CH. Assessment of appropriateness of indications for CT enterography in younger patients. Inflamm Bowel Dis. 2010 Feb; 16 (2):226-32
    View PubMed
  204. Malireddy K, Larson DW, Sandborn WJ, Loftus EV, Faubion WA, Pardi DS, Qin R, Gullerud RE, Cima RR, Wolff B, Dozois EJ. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg. 2010 Jan; 145(1):42-7.
    View PubMed
  205. Pardi DS, Miehlke S. Microscopic colitis. Front Gastrointest Res. 2010; 26:135-45.
  206. Multisociety Task Force, Friedman LS, Brandt LJ, Elta GH, Fitz JG, Gores GJ, Katz PO, Kuemmerle JF, Pardi DS, Vargo JJ, Stolar MH. Report of the Multisociety Task Force on GI training. Hepatology. 2009 Nov; 50(5):1325-9.
    View PubMed
  207. Multisociety Task Force, Friedman LS, Brandt LJ, Elta GH, Fitz JG, Gores GJ, Katz PO, Kuemmerle JF, Pardi DS, Vargo JJ, Stolar MH. Report of the Multisociety Task Force on GI training. Gastrointest Endosc. 2009 Nov; 70(5):823-7.
    View PubMed
  208. Friedman LS, Brandt LJ, Elta GH, Fitz JG, Gores GJ, Katz PO, Kuemmerle JF, Pardi DS, Vargo JJ, Stolar MH. Report of the multisociety task force on GI training. Gastroenterology. 2009 Nov; 137(5):1839-43.
    View PubMed
  209. Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009 Sep; 15 (9):1424-31
    View PubMed
  210. Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis. 2009 Sep; 15 (9):1302-7
    View PubMed
  211. Siddiki HA, Fidler JL, Fletcher JG, Burton SS, Huprich JE, Hough DM, Johnson CD, Bruining DH, Loftus EV Jr, Sandborn WJ, Pardi DS, Mandrekar JN. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol. 2009 Jul; 193 (1):113-21
    View PubMed
  212. Shen B, Pardi DS, Bennett AE, Queener E, Kammer P, Hammel JP, LaPlaca C, Harris MS. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol. 2009 Jun; 104(6):1468-74.
    View PubMed
  213. Hansel SL, Crowell MD, Pardi DS, Bouras EP, DiBaise JK. Prevalence and impact of musculoskeletal injury among endoscopists: a controlled pilot study. J Clin Gastroenterol. 2009 May-Jun; 43(5):399-404.
    View PubMed
  214. Pardi DS. Microscopic colitis. Gastroenterol. Hepatol. 2009; 5(4):283-8.
  215. Limsui D, Pardi DS, Smyrk TC, Abraham SC, Lewis JT, Sanderson SO, Kammer PP, Dierkhising RA, Zinsmeister AR. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 2009 Jan; 15 (1):35-8
    View PubMed
  216. Peloquin JM, Pardi DS, Sandborn WJ, Fletcher JG, McCollough CH, Schueler BA, Kofler JA, Enders FT, Achenbach SJ, Loftus EV Jr. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008 Aug; 103 (8):2015-22 Epub 2008 June 28
    View PubMed
  217. Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, Tremaine WJ, Egan LJ, Faubion WA, Schroeder KW, Pardi DS, Hanson KA, Jewell DA, Barlow JM, Fidler JL, Huprich JE, Johnson CD, Harmsen WS, Zinsmeister AR, Sandborn WJ. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008 Aug; 68 (2):255-66 Epub 2008 June 02
    View PubMed
  218. Pardi DS, Shen B. Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis. Endoscopy. 2008 Jun; 40 (6):529-33 Epub 2008 May 08
    View PubMed
  219. Rubenstein JH, Saini SD, Kuhn L, McMahon L, Sharma P, Pardi DS, Schoenfeld P. Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus. Am J Gastroenterol. 2008 Apr; 103(4):842-9. Epub 2007 Dec 12.
    View PubMed
  220. Pardi DS. Pouchitis patient education brochure. 2008.
  221. Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey. J Cancer Educ. 2007 Winter; 22 (4):208-18
    View PubMed
  222. Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde CN, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ. 2007 Winter; 22 (4):219-26
    View PubMed
  223. Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, Abraham SC. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007 Nov; 5 (11):1282-90; quiz 1245 Epub 2007 Aug 01
    View PubMed
  224. Tremaine WJ, Timmons LJ, Loftus EV Jr, Pardi DS, Sandborn WJ, Harmsen WS, Thapa P, Zinsmeister AR. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease. Aliment Pharmacol Ther. 2007 Jun 15; 25 (12):1435-41
    View PubMed
  225. Akram S, Pardi DS, Schaffner JA, Smyrk TC. Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol. 2007 May; 5 (5):589-96; quiz 523-4
    View PubMed
  226. Oxentenko AS, Pardi DS, Schmoll JA, Gores GJ. Factors predicting initial career choices in gastroenterology fellows. J Clin Gastroenterol. 2007 May-Jun; 41 (5):445-50
    View PubMed
  227. Pardi DS, Loftus EV Jr, Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, Harmsen WS, Zinsmeister AR, Melton LJ 3rd, Sandborn WJ. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007 Apr; 56 (4):504-8 Epub 2006 Nov 29
    View PubMed
  228. Evans PE, Pardi DS. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed. 2007 Mar 19; 9 (1):55
    View PubMed
  229. Limsui D, Pardi DS, Camilleri M, Loftus EV Jr, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007 Feb; 13 (2):175-81
    View PubMed
  230. Evans PE, Pardi DS. Inflammatory bowel disease in the elderly. Aging Health. 2007; 3(1):77-84.
  231. Laing AW, Pardi DS, Loftus EV Jr, Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, Harmsen WS, Zinsmeister AR, Melton LJ 3rd, Melton LJ, Sandborn WJ. Microscopic colitis is not associated with cholecystectomy or appendectomy. Inflamm Bowel Dis. 2006 Aug; 12 (8):708-11
    View PubMed
  232. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther. 2006 Apr 15; 23 (8):1087-96
    View PubMed
  233. Chopra A, Pardi DS, Loftus EV Jr, Tremaine WJ, Egan LJ, Faubion WA, Hanson KA, Johnson TA, Sandborn WJ. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice. Inflamm Bowel Dis. 2006 Jan; 12 (1):29-32
    View PubMed
  234. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005 Aug; 22(4):277-84.
    View PubMed
  235. Fajardo NR, Pardi DS. Practical approach to microscopic colitis and inflammatory bowel disease. Pract Gastroenterol. 2005; 29(12):19-21, 25-26, 29.
  236. Sandborn WJ, Pardi DS. Clinical management of pouchitis. Gastroenterology. 2004 Dec; 127 (6):1809-14
    View PubMed
  237. Pardi DS. Microscopic colitis: an update. Inflamm Bowel Dis. 2004 Nov; 10 (6):860-70
    View PubMed
  238. Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther. 2004 Fall-Winter; 30(3):134-40.
    View PubMed
  239. Smoot RL, Gostout CJ, Rajan E, Pardi DS, Schleck CD, Harmsen WS, Zinsmeister AR, Nolte T, Melton LJ. Is early colonoscopy after admission for acute diverticular bleeding needed? Am J Gastroenterol. 2003 Sep; 98 (9):1996-9
    View PubMed
  240. Kakar S, Pardi DS, Burgart LJ. Colonic ulcers accompanying collagenous colitis: Implication of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 2003 Aug; 98(8):1834-7.
    View PubMed
  241. Pardi DS. Microscopic colitis. Mayo Clin Proc. 2003 May; 78(5):614-6; quiz 616-7.
    View PubMed
  242. Romero Y, Thistle JL, Longstreth GF, Harmsen WS, Schleck CD, Zinsmeister AR, Pardi DS, Zein CO, Van Dyke CT, Arora AS, Locke GR. A questionnaire for the assessment of biliary symptoms. Am J Gastroenterol. 2003 May; 98(5):1042-51.
    View PubMed
  243. Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003 Apr; 124 (4):889-93
    View PubMed
  244. Pardi, D. Concise reveiw for clinicians: microscoic colitis Mayo Clinic Proceedings. 2003; 78:614-617.
  245. Pardi DS, Ramnath VR, Loftus EV, Tremaine WJ, Sandborn WJ. Lymphocytic colitis: Clinical features, treatment, and outcomes. Am J Gastroenterol. 2002 Nov; 97(11):2829-33.
    View PubMed
  246. Pardi DS, Miller SM, Miller DL, Burgart LJ, Szurszewski JH, Lennon VA, Farrugia G. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol. 2002 Jul; 97(7):1828-33.
    View PubMed
  247. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: A review. Am J Gastroenterol. 2002 Apr; 97(4):794-802.
    View PubMed
  248. Pardi DS, Loftus EV Jr, Camilleri M. Treatment of inflammatory bowel disease in the elderly: an update. Drugs Aging. 2002; 19 (5):355-63
    View PubMed
  249. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001 Sep; 96(9):2671-6.
    View PubMed
  250. Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001 Aug; 46 (8):1787-90
    View PubMed
  251. Yassin SF, Young-Fadok TM, Zein NN, Pardi DS. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc. 2001 Jul; 76 (7):725-30
    View PubMed
  252. Chiorean MV, Morford RG, Bivins MH, Pardi DS. Iliac arteriovenous fistula with renal insufficiency, ascites, hepatomegaly, and abnormal liver test results. Mayo Clin Proc. 2001 Jun; 76: (6)661-3.
    View PubMed
  253. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001 May; 120 (6):1483-4
    View PubMed
  254. Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr, Poland GA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Early measles virus infection is associated with the development of inflammatory bowel disease. Am J Gastroenterol. 2000 Jun; 95(6):1480-5.
    View PubMed
  255. Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr, Poland GA, Melton LJ 3rd, Melton LJ 3rd. Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease. Inflamm Bowel Dis. 1999 May; 5 (2):104-6
    View PubMed
  256. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ, Alexander GL, Balm RK, Gostout CJ. Acute major gastrointestinal hemorrhage in inflammatory bowel disease. Gastrointest Endosc. 1999 Feb; 49 (2):153-7
    View PubMed
  257. Pardi DS, Tremaine WJ, Rothenberg HJ, Batts KP. Melanosis coli in inflammatory bowel disease. J Clin Gastroenterol. 1998 Apr; 26 (3):167-70
    View PubMed
  258. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998 Apr; 93 (4):504-14
    View PubMed
  259. Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol. 1998 Mar; 93(3):468-70.
    View PubMed
  260. Pardi DS, Tremaine WJ. Inflammatory bowel disease: keys to diagnosis and treatment. Consultant. 1998 Jan; 38(1):87-92, 96, 98.
PST-20220436